Indeed, a large meta-analysis of cytokine measurements in ARDS patients of different causes revealed lower levels of inflammatory markers, such as IL-6 and TNF-α, in COVID-19-associated ARDS (49). This evidence concerns the gene IL6 and acute respiratory distress syndrome.